NCT06748586View on ClinicalTrials.gov

The Effect of Hyperbaric Oxygen Therapy on Circulating Hematopoietic Stem Cell Population

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 30, 2025

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2027

Conditions
Circulating Hematopoietic Stem Cells
Interventions
DEVICE

Hyperbaric Oxygen Therapy

The HBOT protocol is 90 minutes, 5 times/week, for at least 40 sessions, 100% oxygen at 2 ATA with five-minute air breaks every 20 minutes. Investigational product: Multiplace hyperbaric oxygen chamber (Haux Starmed 2700, Germany) located at the Sagol center for hyperbaric medicine and research, Shamir (Assaf-Harofeh) Medical Center, Israel.

Trial Locations (1)

70300

The Sagol Center for Hyperbaric Medicine and Research Shamir Medical Center (Assaf Harofeh), Zrifin

All Listed Sponsors
lead

Assaf-Harofeh Medical Center

OTHER_GOV